×
ADVERTISEMENT

OCTOBER 27, 2023

FDA Approves Omvoh for Adults With Moderately to Severely Active Ulcerative Colitis


Originally published by our sister publication Pharmacy Practice News

By PPN Staff

The FDA approved mirikizumab-mrkz (Omvoh, Eli Lilly) infusion for the treatment of moderately to severely active ulcerative colitis (UC) in adults.